599 results on '"Oberlin, O"'
Search Results
102. Les tumeurs mésenchymateuses du nouveau-né
103. Ostéoporose et cancers de l’enfant et de l’adolescent
104. Ovarian function after high-dose chemotherapy in childhood: Risk factors for developing partial ovarian failure and how to identify them early
105. A prognostic score at diagnosis for Ewing tumor patients with metastatic disease at extrapulmonary sites
106. Mortalité globale et par maladies cardiovasculaires à long terme après traitement d’un cancer de l’enfant : rôle du traitement
107. SFCE-P05 – Cancérologie – Esthésioneuroblastome des enfants et adolescents
108. SFCE-P08 – Cancérologie – Séquelles endocriniennes après autogreffe de moelle
109. Long-term overall and cardiovascular mortality following childhood cancer: the role of cancer treatment.
110. Ifosfamide versus cyclophosphamide: Long term gonadal effects in 166 male survivors of childhood cancer
111. Prognostic factors in metastatic rhabdomyosarcoma (RMS): The results of a pooled analyze from U.S. and European cooperative groups
112. Extra-abdominal fibromatosis: Can aggressive management be avoided in a subgroup of patients?
113. Long-term evaluation of ifosfamide-related nephrotoxicity in children: The French experience
114. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: A case-control study
115. Overall and cause specific long term mortality following childhood cancer: The role of cancer treatment
116. Multivariate analysis based risk grouping of ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study
117. 2639
118. Résultats fonctionnels de la chirurgie conservatrice et de la curiethérapie comme traitement conservateur des rhabdomyosarcomes vésicoprostatiques
119. A French Pediatric Cancer Survivor Prospective Study: Design and Characteristics
120. Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour
121. P1-9 - Schéma d’actualisation et caractéristiques d’une cohorte française de survivants d’un cancer de l’enfant
122. Breast cancer (BC) risk among 3-year survivors of a first pediatric cancer (FC)
123. SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS)
124. Extra osseous Ewing's tumors: Which is the most appropriate treatment? Experience of the French and International Societies of Pediatric Oncology (SFOP and SIOP)
125. 741 Late effects of paediatric bone marrow transplantation. Results of a single institution
126. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
127. Randomised trial comparing high-dose-methotrexate plus doxorubicine versus high-dose-methotrexate plus etoposide-ifosfamide as preoperative treatment for osteosarcomas
128. Synovial sarcoma in children and adolescents: experience of the International Society of Paediatric Oncology (SIOP)
129. Does myeloablative BuMel therapy improve survival of poor-risk localized tumor of the Ewing family (ET)? Experience of the French Society of Pediatric Oncology (SFOP)
130. Treatment of non metastatic peripheral primitive neuroectodermal tumour (PNET)/Extra osseous Ewing's sarcoma (EOES): experience in the SIOP MMT 89 study
131. High-dose busulfan + melphalan (BuMel) with autologous stem cell support for metastatic Ewing's tumor (ET). The experience of the French Society of Pediatric Oncology, EW91 study
132. The elective place of radiation therapy (RT) in the management of localized soft tissue sarcomas (STS) in children. An update of the MMT 89 study of the International Society of Pediatric Oncology (SIOP)
133. Prognostic factors in patients with localised tumor of the Ewing family (ET). Update of the EW88 study of the French Society of Pediatric Oncology (SFOP)
134. 114 The place of brachytherapy (bt) in the conservative approach of pediatric vesicoprostatic rhabdomyosarcomas (RMS) treatment
135. Treatment of Non-Metastatic Rhabdomyosarcomas in Childhood and Adolescence. Results of the Second Study of the International Society of Paediatric Oncology: MMT84
136. High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma
137. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment
138. Esperance De Vie A Long Terme Des Patients Longs Survivants Apres Traitement D'une Tumeur Solide De L'enfance
139. Prognosis of Children with Malignant Pheochromocytoma
140. Les associations chimioradiothérapiques dans les tumeurs de l'enfant
141. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84
142. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique.
143. Effets tardifs de la radiothérapie chez l'enfant
144. Genetic predisposition to multiple cancers
145. Evaluation of minimal and residual disease (MRD) in Ewing's tumors (ET) at diagnosis and during treatment
146. Les synovialosarcomes [ss] non metastatiques de l'enfant et de l'adolescent. experience de la societe internationale d'oncologie pediatrique [siop]
147. Traitement a visee conservatrice des rhabdomyo sarcomes [rms] non metastatiques de la vessie
148. Traitement des fibrosarcomes [fs] de l'enfant
149. 15 The role or radiation therapy (RT) in the management of localized soft tissue sarcomas (STS) in children a report of the international society of pediatric oncology (SIOP)
150. Present and future strategies of treatment in childhood Hodgkin's lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.